Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema
- PMID: 11530068
- DOI: 10.1016/s0002-9394(01)01010-8
Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema
Abstract
Purpose: To report the clinical outcome of a diabetic patient with macular edema treated with an intravitreal injection of crystalline cortisone.
Methods: Interventional case report. A 73-year-old patient with diabetes mellitus presented with clinically significant diffuse macular edema caused by nonproliferative diabetic retinopathy. Despite grid laser coagulation in the macular region, cystoid macular edema progressed, and within 6 months before the cortisone injection, visual acuity declined from 0.25 to 0.16 and, finally, to 0.10. The patient received a single intravitreal injection of triamcinolone acetonide with topical anesthesia.
Results: After the intravitreal injection of triamcinolone acetonide, visual acuity improved from 0.10 to 0.40 during the follow-up period spanning 5 months. Intraocular pressure increased to values up to 30 mm Hg before antiglaucomatous treatment.
Conclusion: Intravitreal injection of triamcinolone acetonide may be useful for treatment of diabetic macular edema resistant to conventional therapy.
Similar articles
-
Intravitreal cortisone injection for refractory diffuse diabetic macular edema.Ophthalmologica. 2005 Nov-Dec;219(6):394-400. doi: 10.1159/000088385. Ophthalmologica. 2005. PMID: 16286802
-
Intravitreal injection of triamcinolone for diffuse diabetic macular edema.Arch Ophthalmol. 2003 Jan;121(1):57-61. Arch Ophthalmol. 2003. PMID: 12523885 Clinical Trial.
-
Intravitreal triamcinolone acetonide for diabetic macular edema.Retina. 2005 Oct-Nov;25(7):828-34. doi: 10.1097/00006982-200510000-00002. Retina. 2005. PMID: 16205559
-
Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.Acta Ophthalmol Scand. 2005 Dec;83(6):645-63. doi: 10.1111/j.1600-0420.2005.00592.x. Acta Ophthalmol Scand. 2005. PMID: 16396641 Review.
-
[Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].Ophthalmologe. 2004 Feb;101(2):113-20. doi: 10.1007/s00347-003-0982-0. Ophthalmologe. 2004. PMID: 14991306 Review. German.
Cited by
-
Posterior subtenon triamcinolone acetonide in gas-filled eyes as an adjunctive treatment for complicated proliferative diabetic retinopathy.Korean J Ophthalmol. 2013 Feb;27(1):28-33. doi: 10.3341/kjo.2013.27.1.28. Epub 2013 Jan 9. Korean J Ophthalmol. 2013. PMID: 23372376 Free PMC article.
-
Geographic pattern of central retinal sensitivity after intravitreal triamcinolone for diabetic macular edema.Graefes Arch Clin Exp Ophthalmol. 2011 Jan;249(1):3-9. doi: 10.1007/s00417-010-1447-1. Epub 2010 Jul 24. Graefes Arch Clin Exp Ophthalmol. 2011. PMID: 20658146
-
Endophthalmitis after intravitreal injections versus cataract surgery: a 15-year cohort.Int Ophthalmol. 2020 Jan;40(1):73-79. doi: 10.1007/s10792-019-01153-1. Epub 2019 Aug 14. Int Ophthalmol. 2020. PMID: 31414274
-
Diabetic macular edema: Evidence-based management.Indian J Ophthalmol. 2018 Dec;66(12):1736-1750. doi: 10.4103/ijo.IJO_1240_18. Indian J Ophthalmol. 2018. PMID: 30451174 Free PMC article. Review.
-
Intraocular pressure after intravitreal injection of triamcinolone acetonide.Br J Ophthalmol. 2003 Jan;87(1):24-7. doi: 10.1136/bjo.87.1.24. Br J Ophthalmol. 2003. PMID: 12488256 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical